Skip to main content
Nephron is fully inspected and approved by the FDA!
Close

InnoVision Awards to recognize this Columbia CEO for achievement

October 14, 2022

Lou Kennedy, CEO and owner of Nephron Pharmaceuticals, will receive InnoVision’s 2022 Dr. Charles Townes Individual Achievement Award at the virtual InnoVision Awards Ceremony on Nov 15.

The Charles Townes award honors individuals who have exhibited a sustained commitment to the advancement of technology and the community through their technology-oriented and innovative contributions, according to an InnoVision Awards news release. Kennedy is a recognized leader and an advocate for innovation — at Nephron Pharmaceuticals, in the South Carolina bioscience community, and within the state overall, the release stated. 

Read the entire story from the Columbia Regional Business Report here.